IP Library Granted Patent US 7,879,356
Granted Patent B2
US 7,879,356 · App. 09/804,745 · Granted Feb 1, 2011

Polymeric compositions

Assignee: Synthemed, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,879,356
App. No.
09/804,745
Granted
Feb 1, 2011
Kind
B2
Abstract

The present invention relates to novel bioabsorbable polymeric compositions based upon AB polyester polyether or related diblocks and triblocks. Compositions according to the present invention may be used in medical applications, for example, for reducing or preventing adhesion formation subsequent to medical procedures such as surgery, for producing surgical articles including stents and grafts, as coatings, sealants, lubricants, as transient barriers in the body, for materials which control the release of bioactive agents in the body, for wound and burn dressings and producing biodegradable articles, among numerous others.

Claims (19)

1. A biodegradable or bioerodible polymeric composition consisting essentially of hydrophilically crosslinked AB diblocks, where A is a polyester unit derived from the polymerization of monomers selected from the group consisting of lactic acid, lactide, glycolic acid, glycolide, β-propiolactone, ε-caprolactone, δ-glutarolactone, δ-valerolactone, β-butyrolactone, pivalolactone, α,α-diethylpropiolactone, ethylene carbonate, trimethylene carbonate, γ-butyrolactone, p-dioxanone, 1,4-dioxepan-2-one, 3-methyl-1,4-dioxane-2,5-dione, 3,3,-dimethyl-1-4-dioxane-2,5-dione, cyclic esters of α-hydroxybutyric acid, α-hydroxyvaleric acid, α-hydroxyisovaleric acid, α-hydroxycaproic acid, α-hydroxy-α-ethylbutyric acid, α-hydroxyisocaproic acid, α-hydroxy-α-methyl valeric acid, α-hydroxyheptanoic acid, α-hydroxystearic acid, α-hydroxylignoceric acid, salicylic acid and mixtures, thereof and B is a polyoxyalkylene polymer which is end-capped with a non-reactive group, said AB diblock being further reacted with one or more water soluble or water dispersible crosslinking agents to produce crosslinked diblock polymers wherein said crosslinking agents comprise (poly)ethylene oxide chains or (poly)ethylene oxide-co-(poly)propylene oxide chains.

2. The composition according to claim 1 wherein said non-reactive group is an alkyl, aryl, aralkyl, substituted alkyl, substituted aryl, substituted aralkyl, a protecting group or a —C═C— containing group.

3. The composition according to claim 2 wherein said non-reactive group is a C 1 -C 12 alkyl group.

4. The composition according to claim 1 wherein said polyester comprises poly(hydroxy carboxylic acid).

5. The composition according to claim 1 wherein said polyester is obtained from polymerization of an aliphatic hydroxycarboxylic acid or ester selected from the group consisting of L-lactic acid, D,L-lactic acid, glycolic acid, L-lactide, D,L-lactide, glycolide, caprolactone or mixtures thereof.

6. The composition according to claim 2 wherein said non-reactive group is an optionally substituted alkyl group.

7. The composition according to claim 6 wherein said non-reactive group is a methyl group.

8. The composition according to claim 7 wherein said polyoxyalkylene polymer is a polyethyleneoxide polymer.

9. The composition according to claim 1 wherein A is a polyester unit derived from the polymerization of lactide monomers.

10. The composition according to claim 2 wherein A is a polyester unit derived from the polymerization of lactide monomers.

11. The composition according to claim 3 wherein A is a polyester unit derived from the polymerization of lactide monomers.

12. The composition according to claim 6 wherein A is a polyester with derived from the polymerization of lactide monomers.

13. The composition according to claim 7 wherein A is a polyester unit derived from the polymerization of lactide monomers.

14. The composition according to claim 8 wherein A is a polyester unit derived from the polymerization of lactide monomers.

15. The composition according to claim 9 wherein said polyoxyalkylene polymer is a polyethyleneoxide polymer.

16. The composition according to claim 10 wherein said polyoxyalkylene polymer is a polyethyleneoxide polymer.

17. The composition according to claim 11 wherein said polyoxyalkylene polymer is a polyethyleneoxide polymer.

18. The composition according to claim 12 wherein said polyoxyalkylene polymer is a polyethyleneoxide polymer.

19. The composition according to claim 13 wherein said polyoxyalkylene polymer is a polyethyleneoxide polymer.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2014
From: PATHFINDER CELL THERAPY, INC.
To: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
Reel/Frame 031905/0199 →
CHANGE OF NAME Recorded Jun 26, 2013
From: SYNTHEMED, INC
To: PATHFINDER CELL THERAPY, INC.
Reel/Frame 030694/0983 →
SECURITY AGREEMENT Recorded Sep 16, 2010
From: SYNTHEMED, INC.
To: PATHFINDER, LLC
Reel/Frame 025000/0207 →
CHANGE OF NAME Recorded Apr 29, 2009
From: LIFE MEDICAL SCIENCES, INC.
To: SYNTHEMED, INC.
Reel/Frame 022614/0047 →
Continuity (3)
Division 0900666400 · Jan 13, 1998
Continuation In Part 0889080200 · Jul 11, 1997
Related Publication 20010009662A1 · Jul 26, 2001